학술논문

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Document Type
Article
Source
In: Circulation. (Circulation, 6 February 2024, 149(6):450-462)
Subject
Language
English
ISSN
15244539
00097322